Picture of Intra-Cellular Therapies logo

ITCI — Intra-Cellular Therapies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Intra-Cellular Therapies jumps after J&J to buy co for $14.6 billion

** Shares of Intra-Cellular Therapies  ITCI.O  rise 35.6% to
$128.65 premarket
    ** Johnson & Johnson  JNJ.N  will buy ITCI for around $14.6
billion 
    ** JNJ will buy all of ITCI shares for $132/share,
representing a 39% premium to its Friday closing price
    ** ITCI rose 16.6% in 2024

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))

Recent news on Intra-Cellular Therapies

See all news